Whether it’s a globally operating corporation or a small biotech startup, drug discovery is shaped not only by science but also by business decisions. The introduction of, and commitment to, a software architecture is no exception. That’s why it’s important to consider the aspects of software that go beyond the algorithms, such as how cost-effectively a solution can be introduced, how quickly onboarding works, and which functionalities are covered.
In this webinar, we look at the BioSolveIT product portfolio from a business perspective to show how a company can increase efficiency and reduce costs over the long term. Using concrete drug discovery use cases, we provide an overview of synergies across modalities and explore key decision factors for both large enterprises and young companies.
Why people from large organizations should join:
-
Align on an enterprise-ready software strategy (integration, governance, security) beyond “best algorithm.”
-
See how portfolio synergies speed hit-to-lead and lead optimization across teams.
-
Get decision criteria and ROI angles grounded in real drug discovery use cases.
Why people from startups and growing teams should join:
-
Learn how to get productive fast (onboarding in hours, not weeks) with limited headcount.
-
Understand the real cost/effort trade-offs vs open-source (TCO, maintenance, integration).
-
Discover how ultra-large, makeable chemical space can boost speed, novelty/IP, and partnering leverage.
